Correlation of protein expression and gene expression in acute leukemia

被引:38
作者
Kern, W [1 ]
Kohlmann, A
Wuchter, C
Schnittger, S
Schoch, C
Mergenthaler, S
Ratei, R
Ludwig, WD
Hiddemann, W
Haferlach, T
机构
[1] Univ Munich, Univ Hosp Grosshadern, Dept Internal Med 3, Lab Leukemia Diagnost, D-81366 Munich, Germany
[2] Humboldt Univ, Charite, Robert Rossle Klin, Helios Klinikum Berlin, Berlin, Germany
来源
CYTOMETRY PART B-CLINICAL CYTOMETRY | 2003年 / 55B卷 / 01期
关键词
oligonucleotide microarrays; immunophenotyping; acute myeloid leukemia; acute lymphoblastic leukemia; gene expression; protein expression;
D O I
10.1002/cyto.b.10025
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Flow cytometry (FC) is a standard method for diagnosing and subclassifying acute myeloid (AML) and acute lymphoblastic (ALL) leukemias and allows the analysis of cell surface and intracellular proteins. In the future, diagnostic procedures may include oligonucleotide microarray analysis (MA) to detect expression patterns of large numbers of specific genes. Methods: For comparison between methods, we performed FC and MA by using the Affymetrix GeneChip HG-U133A microarray in parallel and correlated protein expression levels and mRNA abundance of 39 relevant genes in 113 patients with newly diagnosed AML and ALL and four normal bone marrow samples. Results: In 1,512 of 2,187 (69.1%) comparisons between methods, congruent results were obtained with regard to positivity or negativity of expression, respectively. Specifically, there was a significant correlation between protein expression and mRNA abundance for genes essential for diagnosing and subclassifying AML and ALL with regard to positivity and expression. Conclusions: These data suggest that protein expression is highly correlated to mRNA abundance in AML and ALL. Further, expression patterns of specific genes provide important information at diagnosis for patients with AML and ALL that may be used for the discrimination from other leukemias. Cytometry Part B (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 23 条
[1]   Proteomic analysis of human prostate cancer [J].
Ahram, M ;
Best, CJM ;
Flaig, MJ ;
Gillespie, JW ;
Leiva, IM ;
Chuaqui, RF ;
Zhou, G ;
Shu, HJ ;
Duray, PH ;
Linehan, WM ;
Raffeld, M ;
Ornstein, DK ;
Zhao, YM ;
Petricoin, EF ;
Emmert-Buck, MR .
MOLECULAR CARCINOGENESIS, 2002, 33 (01) :9-15
[2]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[3]   MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia [J].
Armstrong, SA ;
Staunton, JE ;
Silverman, LB ;
Pieters, R ;
de Boer, ML ;
Minden, MD ;
Sallan, SE ;
Lander, ES ;
Golub, TR ;
Korsmeyer, SJ .
NATURE GENETICS, 2002, 30 (01) :41-47
[4]  
Borowitz MJ, 1997, CYTOMETRY, V30, P236, DOI 10.1002/(SICI)1097-0320(19971015)30:5<236::AID-CYTO4>3.0.CO
[5]  
2-F
[6]   Immunophenotyping of leukemia [J].
Campana, D ;
Behm, FG .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 243 (1-2) :59-75
[7]  
Czuczman MS, 1999, BLOOD, V93, P3931
[8]   Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry [J].
Falini, B ;
Mason, DY .
BLOOD, 2002, 99 (02) :409-426
[9]   Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring [J].
Golub, TR ;
Slonim, DK ;
Tamayo, P ;
Huard, C ;
Gaasenbeek, M ;
Mesirov, JP ;
Coller, H ;
Loh, ML ;
Downing, JR ;
Caligiuri, MA ;
Bloomfield, CD ;
Lander, ES .
SCIENCE, 1999, 286 (5439) :531-537
[10]   World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3835-3849